Participant flow16

How many started, completed or left each group, period by period.

1 to 16 of 16

Period	Milestone	Group	Participants
Overall Study	STARTED	Terbinafine 24 Weeks	133
Overall Study	STARTED	Vehicle 24 Weeks	130
Overall Study	STARTED	Terbinafine 48 Weeks	135
Overall Study	STARTED	Vehicle 48 Weeks	128
Overall Study	Safety Population	Terbinafine 24 Weeks	131
Overall Study	Safety Population	Vehicle 24 Weeks	129
Overall Study	Safety Population	Terbinafine 48 Weeks	134
Overall Study	Safety Population	Vehicle 48 Weeks	126
Overall Study	COMPLETED	Terbinafine 24 Weeks	112
Overall Study	COMPLETED	Vehicle 24 Weeks	111
Overall Study	COMPLETED	Terbinafine 48 Weeks	117
Overall Study	COMPLETED	Vehicle 48 Weeks	111
Overall Study	NOT COMPLETED	Terbinafine 24 Weeks	21
Overall Study	NOT COMPLETED	Vehicle 24 Weeks	19
Overall Study	NOT COMPLETED	Terbinafine 48 Weeks	18
Overall Study	NOT COMPLETED	Vehicle 48 Weeks	17

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00443820/flow